Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drugs are usually biotransformed into new chemical species that may have either toxic or therapeutic effects. Drug metabolism studies are routinely performed in laboratory animals but, due to metabolic interspecies differences when compared to man, they are not accurate enough to anticipate the metabolic profile of a drug in humans. Human hepatocytes in primary culture provide the closest in vitro model to human liver and the only model that can produce a metabolic profile of a given drug that is very similar to that found in vivo. However their availability is limited due to the restricted access to suitable tissue samples. The scarcity of human liver has led to optimising the cryopreservation of adult hepatocytes for long-term storage and regular supply. Human hepatocytes in primary culture express typical hepatic functions and express drug metabolising enzymes. Moreover, qualitative and quantitative similarities between in vitro and in vivo metabolism of drugs were observed. Different strategies have been envisaged to prolong cell survival and delay the spontaneous decay of the differentiated phenotype during culture. Thus, hepatocytes represent the most appropriate model for the evaluation of integrated drug metabolism, toxicity/metabolism correlations, mechanisms of hepatotoxicity, and the interactions (inhibition and induction) of xenobiotics and drug-metabolising enzymes. However, in view of limitations of primary hepatocytes, efforts are made to develop alternative cellular models (i.e. metabolic competent CYP-engineered cells stably expressing individual CYPs and transient expression of CYPs by transduction of hepatoma cells with recombinant adenoviruses). In summary, several cellular tools are available to address key issues at the earliest stages of drug development for a better candidate selection and hepatotoxicity risk assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, liverspecific functions of primary hepatocytes relevant for drug development and toxicity studies are rapidly downregulated during their in vitro cultures [57].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [57]
In the citing paper
“Immortalized cell lines can be used in most research instead of primary cells because they offer several advantages, including cost-effectiveness, ease of use, unlimited availability of materials, and the bypassing of ethical concerns associated with animal and human tissue use [14,15,16].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [14]
Citations
Cites
Progress in the reduction, refinement and replacement of animal experimentation
Balls, M., van Zeller, A.-M., & Halder, M. (2000) · DigitalGeorgetown (Georgetown University Library) · Cited by 296
Isolation, Culture and Use of Human Hepatocytes in Drug Research
Gómez-Lechón, M. J., Donato, M. T., Ponsoda, X., Fabra, R., Trullenque, R., & Castell, J. V. (1996) · Elsevier eBooks · doi:10.1016/b978-012163390-5.50007-7 · Cited by 53
Self-citation
Cited by
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
THP-1 cell line: An in vitro cell model for immune modulation approach
Chanput, W., Mes, J. J., & Wichers, H. J. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.08.002 · Cited by 1,393
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationRobust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1326 · Cited by 835
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
A Human Hepatocellular in Vitro Model to Investigate Steatosis
Gómez-Lechón, M. J., Donato, M. T., Martínez-Romero, A., Jiménez, N., Castell, J. V., & O’Connor, J.-E. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.11.004 · Cited by 576
Self-citationInhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Cell lines: Valuable tools or useless artifacts
Kaur, G., & Dufour, J. M. (2012) · Spermatogenesis · doi:10.4161/spmg.19885 · Cited by 510
Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348
Cell Lines: A Tool for In Vitro Drug Metabolism Studies
Gomez-Lechon, M., Donato, M., Lahoz, A., & Castell, J. (2008) · Current Drug Metabolism · doi:10.2174/138920008783331086 · Cited by 300
Self-citationHuman liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246
Fischer, A., Hoeger, S. J., Stemmer, K., Feurstein, D., Knobeloch, D., Nussler, A. K., & Dietrich, D. R. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.006 · Cited by 222
Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results
Yoon, M., Campbell, J. L., Andersen, M. E., & Clewell, H. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.692115 · Cited by 216
Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies
Castell, J. V., Jover, R., Martnez-Jimnez, C. P., & Gmez-Lechn, M. J. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.2.183 · Cited by 212
Self-citationCompetency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199
“Maintaining hepatocytes in a sandwich culture configuration increases and maintains, for relatively long periods of time, albumin secretion; restores a similar polygonal morphology to that of in vivo cells; prevents cell viability loss; enhances secretion of organic compounds, including urea and albumin; increases bas…”
BackgroundSelf-citationToxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 194
Drug-Induced Liver Injury in Humans: The Case of Ximelagatran
Keisu, M., & Andersson, T. B. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_13 · Cited by 171
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.10.013 · Cited by 170
Self-citationPrediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations
Pelkonen, O., Turpeinen, M., Uusitalo, J., Rautio, A., & Raunio, H. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960305.x · Cited by 166
3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies
Mueller, D., Krämer, L., Hoffmann, E., Klein, S., & Noor, F. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.06.024 · Cited by 159
Bioprinted 3D vascularized tissue model for drug toxicity analysis
Massa, S., Sakr, M. A., Seo, J., Bandaru, P., Arneri, A., Bersini, S., Zare-Eelanjegh, E., Jalilian, E., Cha, B.-H., Antona, S., et al. (2017) · Biomicrofluidics · doi:10.1063/1.4994708 · Cited by 158
Opportunities for Use of Human iPS Cells in Predictive Toxicology
Anson, B. D., Kolaja, K. L., & Kamp, T. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.9 · Cited by 145
In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
Gomez-Lechon, M. J., Lahoz, A., Gombau, L., Castell, J. V., & Donato, M. T. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208910 · Cited by 120
Self-citationCosgrove, B. D., King, B. M., Hasan, M. A., Alexopoulos, L. G., Farazi, P. A., Hendriks, B. S., Griffith, L. G., Sorger, P. K., Tidor, B., Xu, J. J., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.002 · Cited by 136
Liver tissue engineering and cell sources: issues and challenges
Palakkan, A. A., Hay, D. C., PR, A. K., TV, K., & Ross, J. A. (2013) · Liver International · doi:10.1111/liv.12134 · Cited by 130
“In vitro models such as sandwich and spheroid culture have been developed to preserve the differentiated functions of hepatocytes (93, 94).”
Background3D Matrices for Anti-Cancer Drug Testing and Development
Gurski, L. A., Petrelli, N. J., Jia, X., & Farach-Carson, M. C. (2010) · Oncology Issues · doi:10.1080/10463356.2010.11883480 · Cited by 130
Comparative analysis of 3D culture methods on human HepG2 cells
Luckert, C., Schulz, C., Lehmann, N., Thomas, M., Hofmann, U., Hammad, S., Hengstler, J. G., Braeuning, A., Lampen, A., & Hessel‐Pras, S. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1677-z · Cited by 130
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127
Kramer, F., Torzewski, J., Kamenz, J., Veit, K., Hombach, V., Dedio, J., & Ivashchenko, Y. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.12.017 · Cited by 126
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121
“Due to direct isolation from tissue, PHHs are the closest model to mimic the phenotype of a hepatocyte in vivo; notably, their plasma membrane maintains active uptake/secretion mechanisms and metabolism [9,17].”
BackgroundLi, M., Yuan, H., Li, N., Song, G., Zheng, Y. Z., Baratta, M., Hua, F., Thurston, A., Wang, J., & Lai, Y. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.008 · Cited by 121
Human hepatocyte functions in a crossed hollow fiber membrane bioreactor
Bartolo, L. D., Salerno, S., Curcio, E., Piscioneri, A., Rende, M., Morelli, S., Tasselli, F., Bader, A., & Drioli, E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.011 · Cited by 119
Zeilinger, K., Schreiter, T., Darnell, M., Söderdahl, T., Lübberstedt, M., Dillner, B., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Andersson, T. B. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0580 · Cited by 118
EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
Katoh, M., Matsui, T., Nakajima, M., Tateno, C., Kataoka, M., Soeno, Y., Horie, T., Iwasaki, K., Yoshizato, K., & Yokoi, T. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001347 · Cited by 118
FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES
Jigorel, É., Vée, M. L., Boursier-Neyret, C., Bertrand, M., & Fardel, O. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004762 · Cited by 112
Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications
Baumann, A., & Kärst, U. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003713527 · Cited by 105
Coordinated induction of drug transporters and phase I and II metabolism in human liver slices
Olinga, P., Elferink, M. G. L., Draaisma, A. L., Merema, M. T., Castell, J. V., Pérez, G., & Groothuis, G. M. M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.008 · Cited by 103
Self-citationReed, L., Arlt, V. M., & Phillips, D. H. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy058 · Cited by 100
Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice
Suemizu, H., Hasegawa, M., Kawai, K., Taniguchi, K., Monnai, M., Wakui, M., Suematsu, M., Ito, M., Peltz, G., & Nakamura, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.124 · Cited by 99
Polypodium leucotomos extract: Antioxidant activity and disposition
Gombau, L., García, F., Lahoz, A., Fabre, M., Roda‐Navarro, P., Majano, P. L., Alonso-Lebrero, J. L., Pivel, J. P., Castell, J. V., Gómez‐Lechón, M. J., et al. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.09.008 · Cited by 98
Self-citationVignati, L., Turlizzi, E., Monaci, S., Grossi, P., de Kanter, R., & Monshouwer, M. (2005) · Toxicology · doi:10.1016/j.tox.2005.08.003 · Cited by 98
Guichard, S. M., Else, R. W., Reid, E. M., Zeitlin, B. D., Aird, R. E., Muir, M., Dodds, M., Fiebig, H., Sadler, P. J., & Jodrell, D. I. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.053 · Cited by 97
Gómez‐Lechón, M. J., Tolosa, L., & Donato, M. T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3277 · Cited by 95
Self-citationSnykers, S., Vanhaecke, T., De Becker, A., Papeleu, P., Vinken, M., Van Riet, I., & Rogiers, V. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-24 · Cited by 86
Chimeric mice with humanized liver
Katoh, M., Tateno, C., Yoshizato, K., & Yokoi, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.11.012 · Cited by 91
Pettinato, G., Ramanathan, R., Fisher, R. A., Mangino, M. J., Zhang, N., & Wen, X. (2016) · Scientific Reports · doi:10.1038/srep32888 · Cited by 90
Moya, M., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.008 · Cited by 89
Self-citationCell-based models to study hepatic drug metabolism and enzyme induction in humans
Vermeir, M., Annaert, P., Mamidi, R. N. V. S., Roymans, D., Meuldermans, W., & Mannens, G. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.75 · Cited by 88
Drug metabolic stability in early drug discovery to develop potential lead compounds
Gajula, S. N. R., Nadimpalli, N., & Sonti, R. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1970178 · Cited by 87
Paixão, P. J. P. A., Gouveia, L. F., & Morais, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.019 · Cited by 87
Tostões, R. M., Leite, S. B., Miranda, J. P., Sousa, M., Wang, D. I. C., Carrondo, M. J. T., & Alves, P. M. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22920 · Cited by 86
Experimental models for predicting drug absorption and metabolism
Alqahtani, S., Mohamed, L. A., & Kaddoumi, A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.802772 · Cited by 86
Ribes‐Koninckx, C., Pareja, E., Agrasot, M. Á. C., Ana Bonora-Centelles, A., Miquel, B. P., Carbó, J. J. V., Aliaga, E. D., Pallardó, J. M., Gómez-Lechón, M. J., & Castell, J. V. (2012) · Cell Transplantation · doi:10.3727/096368912x637505 · Cited by 83
Self-citationIn vitro microscale systems for systematic drug toxicity study
Sung, J. H., & Shuler, M. L. (2009) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-009-0369-y · Cited by 82
Fagerholm, U. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.6.0007 · Cited by 76
Single-nucleus RNA-seq2 reveals functional crosstalk between liver zonation and ploidy
Richter, M. L., Deligiannis, I. K., Yin, K., Danese, A., Lleshi, E., Coupland, P., Vallejos, C. A., Matchett, K. P., Henderson, N. C., Colome-Tatche, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24543-5 · Cited by 75
Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 75
Coe, K. J., Jia, Y., Ho, H. K., Rademacher, P. M., Bammler, T. K., Beyer, R. P., Farin, F. M., Woodke, L., Plymate, S. R., Fausto, N., et al. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001349 · Cited by 75
Stem cell culture engineering – process scale up and beyond
Sharma, S., Raju, R., Sui, S., & Hu, W. (2011) · Biotechnology Journal · doi:10.1002/biot.201000435 · Cited by 71
Štampar, M., Tomc, J., Filipič, M., & Žegura, B. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02576-6 · Cited by 69
The Effect and Mechanism of Tamoxifen-Induced Hepatocyte Steatosis in Vitro
Zhao, F., Xie, P., Jiang, J., Zhang, L., An, W., & Zhan, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034019 · Cited by 65
Noor, F., Niklas, J., Müller‐Vieira, U., & Heinzle, E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.011 · Cited by 67
Towards Multi-Organoid Systems for Drug Screening Applications
Miranda, C. C., Fernandes, T. G., Diogo, M. M., & Cabral, J. M. S. (2018) · Bioengineering · doi:10.3390/bioengineering5030049 · Cited by 67
Chalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66
Tu, M., Sun, S., Wang, K., Peng, X., Wang, R., Li, L., Zeng, S., Zhou, H., & Jiang, H. (2013) · Toxicology · doi:10.1016/j.tox.2013.06.009 · Cited by 63
Cassim, S., Raymond, V., Lapierre, P., & Bilodeau, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190366 · Cited by 60
Regulation of CYP3A genes in the human respiratory tract
Raunio, H., Hakkola, J., & Pelkonen, O. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2003.12.007 · Cited by 60
Nishimura, M., YOSHITSUGU, H., Yokoi, T., Tateno, C., Kataoka, M., Horie, T., Yoshizato, K., & NAITO, S. (2005) · Xenobiotica · doi:10.1080/00498250500307251 · Cited by 60
Lai, Y. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903127234 · Cited by 57
The Use of Hepatocytes to Investigate Drug Toxicity
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_21 · Cited by 51
Self-citationPaixão, P. J. P. A., Gouveia, L. F., & Morais, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.12.007 · Cited by 59
IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
Katoh, M., Matsui, T., Nakajima, M., Tateno, C., Soeno, Y., Horie, T., Iwasaki, K., Yoshizato, K., & Yokoi, T. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002600 · Cited by 59
Development of a Highly Sensitive Cytotoxicity Assay System for CYP3A4-Mediated Metabolic Activation
Hosomi, H., Fukami, T., Iwamura, A., Nakajima, M., & Yokoi, T. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037077 · Cited by 58
Assessment of metabolic capabilities of PLHC-1 and RTL-W1 fish liver cell lines
Thibaut, R., Schnell, S., & Porte, C. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-008-9116-4 · Cited by 57
In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications
Collins, S. D., Yuen, G., Tu, T., Budzinska, M. A., Spring, K. J., Bryant, K., & Shackel, N. A. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch3 · Cited by 56
Gómez-Lechón, M. J., Lahoz, A., Jiménez, N., Castell, J. V., & Donato, M. T. (2006) · Xenobiotica · doi:10.1080/00498250600674352 · Cited by 56
Self-citationIn Vitro Models for Studying Chronic Drug-Induced Liver Injury
Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 54
Self-citationFunctional evolution of the pregnane X receptor
Iyer, M., Reschly, E. J., & Krasowski, M. D. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.381 · Cited by 54
Pillai, V. C., Strom, S. C., Caritis, S. N., & Venkataramanan, R. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.10.016 · Cited by 53
Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review
Sinha, S., Sarma, P., Sehgal, R., & Medhi, B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00754 · Cited by 53
Sex-dependent dynamics of metabolism in primary mouse hepatocytes
Hochmuth, L., Körner, C., Ott, F., Volke, D., Cokan, K. B., Juvan, P., Brosch, M., Hofmann, U., Hoffmann, R., Rozman, D., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03118-9 · Cited by 52
Rivera‐Esteban, J., Muñoz, S., Higuera, M., Sena, E., Bermúdez-Ramos, M., Bañares, J., Martínez-Gómez, M., Cusidó, M. S., Jiménez-Masip, A., Francque, S., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.028 · Cited by 52
Peck, Y., & Wang, D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.751096 · Cited by 52
Application of Chimeric Mice with Humanized Liver for Predictive ADME
Katoh, M., & Yokoi, T. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601021340 · Cited by 52
Corcoran, J., Lange, A., Winter, M. J., & Tyler, C. R. (2012) · Environmental Science & Technology · doi:10.1021/es3005305 · Cited by 52
Kenne, K., Skånberg, I., Glinghammar, B., Berson, A., Pessayre, D., Flinois, J.-P., Beaune, P. H., Edebert, I., Pohl, C. D., Carlsson, S., et al. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.014 · Cited by 52
Castell, J. V., & Gómez-Lechón, M. J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-201-4_4 · Cited by 51
Self-citationMagliocco, G., Desmeules, J. A., Matthey, A., Quirós-Guerrero, L.-M., Bararpour, N., Joye, T., Marcourt, L., Queiroz, E. F., Wolfender, J., Gloor, Y. S., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15651 · Cited by 50
Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes
Blanchard, N., Alexandre, E., Abadie, C., Lavé, T., Heyd, B., Mantion, G., Jaeck, D., Richert, L., & Coassolo, P. (2005) · Xenobiotica · doi:10.1080/00498250400021820 · Cited by 48
Lahoz, A., Donato, M. T., Castell, J. V., & Gómez‐Lechón, M. J. (2008) · Current Drug Metabolism · doi:10.2174/138920008783331112 · Cited by 48
Self-citationNawaz, A., Razpotnik, A., Rouimi, P., de Sousa, G., Cravedi, J., & Rahmani, R. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9266-x · Cited by 48
Li, A. P., Uzgare, A. R., & LaForge, Y. S. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.05.003 · Cited by 48
Zhang, J., Doshi, U., Suzuki, A., Chang, C., Borlak, J. T., Li, A. P., & Tong, W. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.008 · Cited by 47
Chen, S., Wu, Q., Li, X., Li, D., Mei, N., Ning, B., Puig, M., Ren, Z., Tolleson, W. H., & Guo, L. (2021) · Journal of Environmental Science and Health, Part C · doi:10.1080/26896583.2021.1880242 · Cited by 44
DMSO modulates the pathway of apoptosis triggering
Banič, B., Nipič, D., Šuput, D., & Milisav, I. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0007-y · Cited by 44
Goyak, K. O., Johnson, M. C., Strom, S. C., & Omiecinski, C. J. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.04.024 · Cited by 43
Schmitmeier, S., Langsch, A., Jasmund, I., & Bader, A. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21089 · Cited by 43
Ivashchenko, Y., Kramer, F., Schäfer, S., Bucher, A., Veit, K., Hombach, V., Busch, A., Ritzeler, O., Dedio, J., & Torzewski, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150041.81963.68 · Cited by 35
Jaiswal, S., Sharma, A., Shukla, M. K., Vaghasiya, K., Rangaraj, N., & Lal, J. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.967866 · Cited by 42
Metadata
- Authors
- Gomez-Lechon, M., Donato, M., Castell, J., & Jover, R.
- Affiliations
- Hospital Universitari i Politècnic La Fe (ES)
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 292-312
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2112247582
- Cited by
- 242
- References
- 2
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 18 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 16 · 2012: 12
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- human hepatocytes, primary hepatocyte culture, drug metabolism, hepatotoxicity, toxicity prediction, drug-metabolizing enzymes, adenoviral transduction, hepatoma cells, xenobiotic interactions, in vitro-in vivo correlation, drug development
- MeSH terms
- Cells, Cultured, Cytochrome P-450 Enzyme System, Drug Interactions, Pharmaceutical Preparations, Humans, Liver, Models, Biological, Time Factors, Hepatocytes, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.